Literature DB >> 19726825

Very late drug-eluting stent thrombosis related to incomplete stent endothelialization: in-vivo demonstration by optical coherence tomography.

Santiago Jiménez-Valero1, Raúl Moreno, Angel Sánchez-Recalde.   

Abstract

Very late drug-eluting stent (DES) thrombosis is a rare but potentially life-threatening event that has become a major cause of concern. Delayed arterial healing with incomplete endothelialization is probably a pivotal factor related with DES thrombosis. Optical coherence tomography (OCT) is a new high-resolution intracoronary imaging technique that allows detailed evaluation of stent neointimal coverage. We present a case of very late DES thrombosis that was evaluated with OCT, demonstrating incomplete endothelialization as the probable main mechanism of stent thrombosis. This case illustrates the ability of OCT for in-vivo identification of stent coverage and its potential role in the evaluation of stent thrombosis mechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 19726825

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Polymeric stent materials dysregulate macrophage and endothelial cell functions: implications for coronary artery stent.

Authors:  Xintong Wang; Angela L Zachman; Young Wook Chun; Fang-Wen Shen; Yu-Shik Hwang; Hak-Joon Sung
Journal:  Int J Cardiol       Date:  2014-04-25       Impact factor: 4.164

2.  Subacute drug-eluting stent thrombosis caused by stent underexpansion: evaluation by optical coherence tomography.

Authors:  Roberto Martín-Reyes; Santiago Jiménez-Valero; Felipe Navarro; Raúl Moreno
Journal:  Case Rep Med       Date:  2011-02-23

3.  Vascular Healing Response after Everolimus-Eluting Stent Implantation in Acute Coronary Syndrome Culprit Lesions: Comparison with Implantation in Stable Angina Pectoris.

Authors:  Yutaka Goryo; Teruyoshi Kume; Tomoya Ueda; Makoto Watanabe; Ryotaro Yamada; Yoji Neishi; Yoshihiko Saito; Shiro Uemura
Journal:  Acta Cardiol Sin       Date:  2018-03       Impact factor: 2.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.